Committee Membership Key
Grahame Cook
Chair of the Board
Biography
Grahame Cook has 18 years of experience in investment banking focusing on global equity capital markets and M&A and corporate advisory services. He was a Managing Director at UBS and joint Chief Executive of Panmure Gordon. He advised the London Stock Exchange on the creation of TechMark, the specialist segment of the Main Market focusing on innovative technology and healthcare companies. He has experience in the healthcare sector, most recently as Chair of Sinclair Pharma plc and as NonExecutive Director of Morphogenesis Inc. and Horizon Discovery plc. He has also held Board positions in a number of other companies including MDY Healthcare plc and Crawford Healthcare.
He holds a double first-class degree from Oxford University and is a member of the Institute of Chartered Accountants.
Term of office
Grahame Cook was appointed as Non-Executive Director of AMS in February 2021 and as Chair in March 2025
External appointments
Grahame Cook is Chair of Molten plc, a FTSE 250 Company, and a Non-Executive Director of Minoan plc and Sapience Communications Limited.
Chris Meredith
Chief Executive Officer
Biography
Chris Meredith joined AMS as Group Commercial Director in July 2005 following a successful 18-year career in international healthcare sales, marketing and business development. His experience covered business-to-business contract manufacturing, product development and clinical research, as well as branded product sales all within the medical device, pharmaceutical or consumer healthcare markets. Chris has previously held senior positions at Smiths Industries, Cardinal Health, Banner Pharmacaps, and Aster Cephac. He was appointed Managing Director of Advanced Woundcare in February 2008, became Chief Operating Officer in January 2010 and was appointed as Chief Executive Officer in January 2011.
Term of office
Chris Meredith was appointed to the Board in April 2006.
External appointments
Chris Meredith was appointed Chair of Arterius, a UK-based pre-commercial, non-competitive medical device company, in January 2022. He left his role as a Non-Executive Director of Creavo Medical Technology Ltd in November 2021.
Eddie Johnson
Chief Financial Officer
Biography
Eddie Johnson was appointed as Chief Financial Officer in January 2019. He joined AMS in October 2011 and was appointed Group Financial Controller in November 2012. Prior to this he gained a first-class degree in Maths and Computer Science from Keele University in 1993 and qualified as a Chartered Accountant in 1996.
Since moving into industry in 1996 Eddie has held a number of senior finance roles in various sectors including, more recently, Head of Commercial Finance at Norcros plc and Western European Financial Controller for Sumitomo Electrical Wiring Systems.
Term of office
Eddie Johnson was appointed to the Board in January 2019.
External appointments
None.
Susan Searle
Senior Independent Non-Executive Director
Biography
Susan has extensive experience on public and private company boards in a number of sectors, including healthcare. Susan was formerly Non-Executive Senior Independent Director and Remuneration Chair of Horizon Discovery plc and Benchmark Holdings Plc, both technology businesses. She also chaired two listed investment businesses – Mercia Asset Management plc and Schroders UK Public Private Trust plc, and was a founder of Touchstone Innovations plc, where she served as its CEO. She has recently stepped down from QinetiQ plc where she was a Non-Executive Director and Remuneration Committee Chair, having served three full terms. She holds an MA in Chemistry from Oxford University.
Term of office
Susan Searle was appointed as Non-Executive Director in March 2025.
External appointments
Susan Searle is currently a Non-Executive Director of Gooch & Housego plc, where she is Chair of the Remuneration and Sustainability Committees, as well as being a Non-Executive of Bibby Line Group and Chair of Greenback Recycling Technologies Limited.
Douglas Le Fort
Non-Executive Director
Biography
Douglas Le Fort is a seasoned veteran in the medical and life science industry, with more than 20 years of senior executive leadership. He has expertise in business strategy, including commercial business execution, operational management and M&A. Most recently, he was a Non-Executive Director of Clinisupplies, a UK- ased manufacturer of chronic care products, CEO of MedTrade Products, a woundcare products business, and prior to that served in various senior executive roles at ConvaTec Group plc, including five years on the Executive Committee for the group. At ConvaTec he was Senior Vice President for Corporate Development, and prior to that Vice President and General Manager with P&L responsibility for the global Ostomy business.
He has an MBA from Henley Management College and is a Chartered Management Accountant.
Term of office
Douglas Le Fort was appointed as Non-Executive Director of AMS in August 2021 and as the Director responsible for Workforce Engagement in March 2025.
External appointments
Douglas Le Fort is currently Chairman of Advanced Oxygen Therapy Inc. (AOTI), a medical technology group, an Operating Partner for Revival Healthcare Capital Partners, an investor in medical device and diagnostics businesses, as well as a Non-Executive Director at ForLife GmbH, previously Trio Healthcare and a manufacturer of ostomy products, and The Insides Company Ltd, a start-up addressing intestinal failure based in New Zealand.